Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

Salim Y., OĞUZ A.

LANCET, vol.378, no.9798, pp.1231-1243, 2011 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 378 Issue: 9798
  • Publication Date: 2011
  • Doi Number: 10.1016/s0140-6736(11)61215-4
  • Title of Journal : LANCET
  • Page Numbers: pp.1231-1243


Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary prevention medications in these communities. We aimed to assess use of proven effective secondary preventive drugs (antiplatelet drugs, beta blockers, angiotensin-converting-enzyme [ACE] inhibitors or angiotensin-receptor blockers [ARBs], and statins) in individuals with a history of coronary heart disease or stroke.